These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36303639)

  • 1. Women Trust Their OBGYNs to Provide Preexposure Prophylaxis: An Opportunity for HIV Prevention.
    Danvers AA; Chew Murphy E; Avila K; Gonzalez-Argoti T; Edwards AR; Hoffman S; Mantell JE; Bauman LJ; Dolan SM
    Front Reprod Health; 2022; 4():832287. PubMed ID: 36303639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Being able to do whatever you wanna do as a woman is important:" a qualitative exploration of contraception as a frame of reference for HIV prevention with PrEP.
    Murphy EC; Danvers A; Zamudio AR; Avila K; Proehl M; Gonzalez-Argoti T; Mantell JE; Bauman LJ; Dolan SM
    Reprod Health; 2022 Apr; 19(1):92. PubMed ID: 35392943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. United States family planning providers' knowledge of and attitudes towards preexposure prophylaxis for HIV prevention: a national survey.
    Seidman D; Carlson K; Weber S; Witt J; Kelly PJ
    Contraception; 2016 May; 93(5):463-9. PubMed ID: 26772906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic prevention of human immunodeficiency virus in women: practical approaches for the obstetrician and gynecologist.
    Hong JN; Farel CE; Rahangdale L
    Obstet Gynecol Surv; 2015 Apr; 70(4):284-90. PubMed ID: 25900528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-Exposure Prophylaxis Barriers, Facilitators and Unmet Need Among Rural People Who Inject Drugs: A Qualitative Examination of Syringe Service Program Client Perspectives.
    Surratt HL; Yeager HJ; Adu A; González EA; Nelson EO; Walker T
    Front Psychiatry; 2022; 13():905314. PubMed ID: 35706473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preexposure Prophylaxis for Prevention of HIV Acquisition Among Adolescents: Clinical Considerations, 2020.
    Tanner MR; Miele P; Carter W; Valentine SS; Dunville R; Kapogiannis BG; Smith DK
    MMWR Recomm Rep; 2020 Apr; 69(3):1-12. PubMed ID: 32324724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing Delivery of HIV Preexposure Prophylaxis for Women in the United States.
    Aaron E; Blum C; Seidman D; Hoyt MJ; Simone J; Sullivan M; Smith DK
    AIDS Patient Care STDS; 2018 Jan; 32(1):16-23. PubMed ID: 29323558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Readiness for Use of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men in Malawi: Qualitative Focus Group and Interview Study.
    Mpunga E; Persaud N; Akolo C; Boyee D; Kamanga G; Trapence G; Chilongozi D; Ruberintwari M; Masankha Banda L
    JMIR Public Health Surveill; 2021 Oct; 7(10):e26177. PubMed ID: 34228627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers to uptake and use of pre-exposure prophylaxis (PrEP) among communities most affected by HIV in the UK: findings from a qualitative study in Scotland.
    Young I; Flowers P; McDaid LM
    BMJ Open; 2014 Nov; 4(11):e005717. PubMed ID: 25412863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empowering With PrEP (E-PrEP), a Peer-Led Social Media-Based Intervention to Facilitate HIV Preexposure Prophylaxis Adoption Among Young Black and Latinx Gay and Bisexual Men: Protocol for a Cluster Randomized Controlled Trial.
    Patel VV; Ginsburg Z; Golub SA; Horvath KJ; Rios N; Mayer KH; Kim RS; Arnsten JH
    JMIR Res Protoc; 2018 Aug; 7(8):e11375. PubMed ID: 30154071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preexposure prophylaxis for the prevention of HIV transmission to women.
    Aaron E; Cohan D
    AIDS; 2013 Jan; 27(1):F1-5. PubMed ID: 22914582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the Screening and Enrollment of People at Risk of HIV in Mexico's Preexposure Prophylaxis Demonstration Project, 2018-2020.
    Vermandere H; Martínez-Silva G; Aguilera-Mijares S; Martínez-Dávalos A; Bautista-Arredondo S
    Public Health Rep; 2024 Mar; ():333549241230479. PubMed ID: 38491784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A community-based healthcare package combining testing and prevention tools, including pre-exposure prophylaxis (PrEP), immediate HIV treatment, management of hepatitis B virus, and sexual and reproductive health (SRH), targeting female sex workers (FSWs) in Côte d'Ivoire: the ANRS 12381 PRINCESSE project.
    Becquet V; Nouaman M; Plazy M; Agoua A; Zébago C; Dao H; Montoyo A; Jary A; Coffie PA; Eholié S; Larmarange J;
    BMC Public Health; 2021 Dec; 21(1):2214. PubMed ID: 34863122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexual and Reproductive Health Care Visits as a Venue for Preexposure Prophylaxis Service Delivery Among Women in the United States: Results From a Nationally Representative Survey.
    Weigel G; Theva M; Hardy E; Wagner S; Brown B
    Sex Transm Dis; 2023 Nov; 50(11):726-730. PubMed ID: 36943788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which Patients in the Emergency Department Should Receive Preexposure Prophylaxis? Implementation of a Predictive Analytics Approach.
    Ridgway JP; Almirol EA; Bender A; Richardson A; Schmitt J; Friedman E; Lancki N; Leroux I; Pieroni N; Dehlin J; Schneider JA
    AIDS Patient Care STDS; 2018 May; 32(5):202-207. PubMed ID: 29672136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Provider Perspectives on Multi-level Barriers and Facilitators to PrEP Access Among Latinx Sexual and Gender Minorities.
    Gómez W; Gomez AM; Solis S; Dimonte C; Organista KC
    J Racial Ethn Health Disparities; 2024 Feb; ():. PubMed ID: 38381327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Get PrEPPT (pre-exposure prophylaxis and pregnancy termination): an exploration of the values, attitudes and preferences regarding HIV and PrEP among women seeking abortion.
    Ralph JA; Yeh C; Cowett A; Hirschhorn LR; Hammond C
    BMJ Sex Reprod Health; 2021 Jul; 47(3):e6. PubMed ID: 33122259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of HIV Preexposure Prophylaxis Use Behaviors and HIV Incidence Among US Adults in an Integrated Health Care System.
    Hojilla JC; Hurley LB; Marcus JL; Silverberg MJ; Skarbinski J; Satre DD; Volk JE
    JAMA Netw Open; 2021 Aug; 4(8):e2122692. PubMed ID: 34436609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refining a Multicomponent Intervention to Increase Perceived HIV Risk and PrEP Initiation: Focus Group Study Among Black Sexual Minority Men.
    Dangerfield Ii DT; Anderson JN; Wylie C; Arrington-Sanders R; Bluthenthal RN; Beyrer C; Farley JE
    JMIR Form Res; 2022 Aug; 6(8):e34181. PubMed ID: 35947442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV Preexposure Prophylaxis and Treatment as Prevention - Beliefs and Access Barriers in Men Who Have Sex With Men (MSM) and Transgender Women: A Systematic Review.
    Matacotta JJ; Rosales-Perez FJ; Carrillo CM
    J Patient Cent Res Rev; 2020; 7(3):265-274. PubMed ID: 32760758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.